{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-116219","form_type":"8-K","ticker":"INKT","cik":"0001840229","company_name":"MiNK Therapeutics, Inc.","filed_at":"2026-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.481340+00:00","generated_at":"2026-05-15T09:40:56.452555+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"MiNK Therapeutics appoints new Principal Financial Officer and Principal Accounting Officer","bullets":["Melissa Orilall, VP Global Financial Operations at Agenus, appointed Principal Financial Officer effective March 13, 2026.","Austin Charette, Senior Director Financial Reporting & Compliance at Agenus, appointed Principal Accounting Officer effective same date.","Both provide services via Amended Intercompany Services Agreement with Agenus; no direct compensation from MiNK.","No new arrangements or modifications tied to these designations."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-116219","json":"https://secwatch.observer/filing/0001193125-26-116219.json","markdown":"https://secwatch.observer/filing/0001193125-26-116219.md","text":"https://secwatch.observer/filing/0001193125-26-116219.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526116219/0001193125-26-116219-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526116219/inkt-20260313.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:40:56.452555+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}